NICE goes ahead with controversial drug affordability test

By Sharon Brennan2017-03-15T19:12:00

Today the National Institute for Health and Care Excellence has confirmed it will go ahead next month with controversial plans to assess new treatments based on affordability.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here